Hello readers.
Our top stories today include a double feature on the biotechnology sector. While the industry got a huge boost at the hight of the Covid-19 pandemic, it seems to be cooling off now as outside capital looks elsewhere for returns, alongside all the other economic woes challenging the U.S. business world in general.
But there are bright spots. Developers of lab space say — with a few caveats about what type and where — that they are optimistic about life-sciences projects.
Read…
